List of products by Illumina

The NextSeq 550Dx instrument is FDA regulated and CE-in vitro diagnostic (IVD) marked, enabling clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using targeted panels, to clinical research applications that include methods from targeted panels to whole genomes.

The TruSight Oncology 500 portfolio enables in-house, pan-cancer comprehensive genomic profiling (CGP) for solid tumors from either blood or tissue biopsy samples.

The Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT Platform provides accurate, ultra-rapid secondary genomic analysis of sequencing data.

Data management and simplified bioinformatics for labs getting started and for rapidly scaling next-generation sequencing (NGS) operations.

NextSeq 500/550 v2.5 sequencing reagent kits deliver the power of high-throughput sequencing on a benchtop system with increased stability and robustness.

Infinium Omni2.5-8 Kit features ~2.4 million markers, and delivers exceptional genomic coverage rates across diverse populations.

High-throughput, cost-effective genotyping for quality control, tracking, and stratification applications including biobanking.

Illumina COVIDSeq Test detects SARS-CoV-2 in patients suspected of COVID-19 and enables virus genome analysis in research use.

The MiniSeq System performs a broad range of targeted DNA and RNA applications in your own lab on your own schedule.

Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of the project.

The iSeq 100 Sequencing System allows labs of all sizes to sequence DNA and RNA.

Methylation profiling microarray with extensive coverage of CpG islands, genes, and enhancers.

MiSeq Reagent Kits v3 enable the highest output of all MiSeq kits.